Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
about
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceGenetic, hormonal and metabolic aspects of PCOS: an updateMechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainRelationship between Advanced Glycation End Products and Steroidogenesis in PCOSScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS)Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development.A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndromeEstrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vesselsCo-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI.Metabolic syndrome, androgens, and hypertension.Industrial endocrine disruptors and polycystic ovary syndrome.First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.Androgens and hypertension: role in both males and females?Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Influence of ω-3 fatty acid eicosapentaenoic acid on IGF-1 and COX-2 gene expression in granulosa cells of PCOS women.The role of metformin in the management of NAFLDProtein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS)Expression Levels of PPARγ and CYP-19 in Polycystic Ovarian Syndrome Primary Granulosa Cells: Influence of ω-3 Fatty AcidAssociation between Polycystic Ovary Syndrome and Gut Microbiota.Effects of Adiponectin Including Reduction of Androstenedione Secretion and Ovarian Oxidative Stress Parameters In Vivo.Hypertension in postmenopausal women.Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Reduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndrome.Metformin: Midlife maturity, maiden charmMetabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistanceMinireview: stem cell contribution to ovarian development, function, and diseaseCorticosterone regulation of ovarian follicular development is dependent on the energy status of laying hens.Immune regulation of ovarian development: programming by neonatal immune challenge.Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome.Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?Serum leptin changes with metformin treatment in polycystic ovarian syndrome: correlation with ovulation, insulin and testosterone levels.Metabolic syndrome and polycystic ovary syndrome... and vice versa.
P2860
Q24629523-518B97E3-03CE-483B-985C-E7481CC3331CQ26740034-3E2ED083-BA51-44E1-8F3E-2FB2F156BEBFQ28066227-679296B5-4127-4656-8FA0-CD95517792D9Q28077960-1F88681D-7AAB-421A-B66C-CB16491F68C5Q28390200-64EB1C66-8FA7-40B9-8FC9-C37C8AA58849Q28533870-433E2F77-04A7-4BF8-9020-C104D78A9EB1Q33482041-EB1321EC-3047-41D9-95E2-4B10638F456EQ33570233-07498F24-71A1-42A1-BFB1-C63D82203F5EQ33614259-A9F77F71-2A2E-42CB-A66F-9614561E3F46Q33781367-528104E3-FCFB-42B6-99BA-8EC7B7E38357Q33937237-A8796523-4525-40B7-A2DB-04485C2F0144Q34025524-B2ACDB5A-32B2-4FD6-8E50-40EF6C7AB6E2Q34399051-3CC6625B-BB02-4ABD-A72A-7606348EF851Q34421386-7C59683C-FC92-4CFE-A392-EBF2C6C38202Q34496769-B255D41B-5430-4D5F-9C7F-8C6693EC06B7Q34846555-E9B8A298-BD5F-4462-B1FB-3968EB272EFFQ34979189-546B4F5A-23CA-40CA-AA93-0FE13326763CQ35100131-220AF8A8-2FCE-4EC6-B80C-042B62B17CBAQ35589228-82E0BE64-0CEC-4EF4-92BD-0079A2E9819FQ35614956-6373DE76-24B3-449C-B4F0-6FC2EAFC15A5Q35866268-E0DD4D5C-0536-482D-B9DA-E9BA4FDE7ADCQ35898949-DA1E5A62-BC31-41C6-AAFB-47C68FEF2023Q35993883-68196286-B34C-46F8-9890-481E98F2EEEBQ36012055-8F629289-D9F1-42ED-B6C9-BBFEC7231C7CQ36082076-51679CF3-4ACD-4901-AEF5-7F815EDA3F62Q36176816-1150668E-AA50-4A80-B901-B8313485C5F8Q36328060-5D68A5F9-7D30-4E2F-807C-FE70086A03ECQ36434349-843F0706-DA5E-46DE-B55A-0EC60F62A71DQ36436404-4D742333-9A1B-46F2-B5EE-4CDAA2C521B7Q36690815-D8BA0B83-2F67-4F32-A952-70635A831BD3Q36816280-FCDA9B74-9C69-4BBF-B22D-BBF2D58C2D40Q36908928-609AE04C-F1EC-4D29-A68A-007465279D09Q36920579-CE696BC1-1E7A-4F93-BCDF-44132A947CB3Q36920850-7EF764B0-19BA-4F9D-AD11-71071DEE56BEQ37049958-0A512F89-289A-47CC-AAE6-B8245B9F36ECQ37057461-B9A0C5B2-EE94-4D2F-ACB0-87B5600EABF0Q37139461-A49B0181-FB17-4B7E-B3BB-366B529FCB37Q37264532-00F8D7C8-04C1-4C17-8D54-BE923475189DQ37413811-60414418-39C2-4FD1-A801-66B8FC393436Q37494304-3A77BE05-080B-4441-A823-812D6735F246
P2860
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@en
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@nl
type
label
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@en
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@nl
prefLabel
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@en
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@nl
P2860
P1476
Polycystic ovarian syndrome: p ...... cts and clinical implications.
@en
P2860
P356
10.1017/S1462399408000598
P577
2008-01-30T00:00:00Z